Latest Manufacturing News

Imugene Limited reports a complete response in the first patient treated with azer-cel combined with BTK inhibitors in its Phase 1b trial, highlighting potential for resistant follicular lymphoma.

Papyrus Australia reached a key production milestone by delivering 200 biodegradable Collar Keeper® samples to TBS Mining Solutions, confirming its manufacturing scalability. The company’s May cash flow shows a steady funding runway amid ongoing R&D and commercialisation efforts.

Euro Manganese has filed comprehensive NI 43-101 and JORC reports for its Chvaletice Manganese Project, confirming robust economics with a base case post-tax NPV of US$492 million and an upside scenario pushing NPV to US$798 million, driven by higher manganese prices.

Almonty Industries has been added to the Russell 1000 and 3000 indexes, marking a key milestone in its market capitalization growth and enhancing its visibility among institutional investors.

AnteoTech has shipped a 20-litre sample of its new Anteo C primer coating additive to a South Korean manufacturer, marking a key step from lab trials to manufacturing-scale evaluation in lithium-ion battery production.

Sparc Technologies has unveiled SparcESTM, a graphene additive range designed for electrostatic and conductive coatings, aiming to disrupt a $1.65 billion market driven by data centres, semiconductors, and EV battery manufacturing.

GCM Corporation has inked a binding 24-month joint development agreement with Shenzhen Wanwei Heat Conduction Technology (ALVC) to co-develop a hybrid thermal management product combining vapour chamber and VHD heat sink technologies.

Metals Australia’s prefeasibility study for its Lac Carheil Graphite Project in Quebec reveals a strong economic foundation with a pre-tax NPV of AUD 790.8 million and a 22% IRR, underpinning its potential as a significant future graphite supplier.

BauMart has reached a pivotal milestone in its BuildMart Modular project with the delivery of four modular homes to Fremantle, marking a practical demonstration of offsite construction's efficiency and quality.

Clarity Pharmaceuticals will present compelling data at EANM 2026 demonstrating its 64Cu-SAR-bisPSMA imaging agent’s superior detection of prostate cancer recurrence and promising therapeutic results from 67Cu-SAR-bisPSMA in advanced disease.

Lumos Diagnostics has received a A$709,837 cash refund from the Australian Government’s R&D Tax Incentive, bolstering its investment in proprietary point-of-care diagnostic technologies.

Verbrec has secured a $21 million contract to upgrade the McArthur River Pipeline, enabling commercial gas flow from the Beetaloo sub-basin and bolstering Northern Territory's energy security.